Cancer Family
Malignant Neoplasm
CI-CAN-00000025CAExplore in graph →
20,126 active trials259 approved drugs3,742 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000025CAExplore in graph →
Clinical trials
90,710 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (11,169)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02190279 | 18F-DCFBC PET/CT in Prostate Cancer | completed | Early Phase 1 | 116 | National Cancer Institute (NCI)NIH | 1 | Apr 23, 2019 | clinicaltrials |
| NCT02392039 | Study of Loratadine for Pegfilgrastim Induced Bone Pain in Patients With Aggressive Lymphoma | terminated | Early Phase 1 | 1 | M.D. Anderson Cancer CenterOTHER | 1 | Apr 23, 2019 | clinicaltrials |
| NCT03923998 |
| Adjuvant ChemoRadiotherapy Prior to Surgery in Stage IVa Oral Cancers |
| completed |
| Early Phase 1 |
| 8 |
| Indrayani Hospital and Cancer InstituteOTHER |
| 1 |
| Apr 23, 2019 |
| clinicaltrials |
| NCT03291353 | Phase 0- Pilot Study of Pembrolizumab on Immune Cells in Patient With Refractory Acute Myeloid Leukemia | withdrawn | Early Phase 1 | 0 | Michael BoyiadzisOTHER | 1 | Apr 19, 2019 | clinicaltrials |
| NCT01594242 | Autophagy Induction After Bortezomib for Myeloma | completed | Early Phase 1 | 11 | Abramson Cancer Center at Penn MedicineOTHER | 1 | Apr 16, 2019 | clinicaltrials |
| NCT02735356 | Topical Itraconazole in Treating Patients With Basal Cell Cancer | completed | Early Phase 1 | 9 | Jean Yuh TangOTHER | 1 | Apr 11, 2019 | clinicaltrials |
| NCT03799913 | MESO-CAR T Cells Therapy for Relapsed and Refractory Ovarian Cancer | unknown | Early Phase 1 | 20 | Zhejiang UniversityOTHER | 1 | Apr 10, 2019 | clinicaltrials |
| NCT00908791 | Proof of Principle Trial to Determine if Nutritional Supplement Conjugated Linoleic Acid (CLA) Can Modulate the Lipogenic Pathway in Breast Cancer Tissue | completed | Early Phase 1 | 24 | Dartmouth-Hitchcock Medical CenterOTHER | 1 | Apr 1, 2019 | clinicaltrials |
| NCT02610920 | Sentinel Lymph Node Identification in the Axilla of Women With Breast Cancer Using Ultrasound and Iron Injection | withdrawn | Early Phase 1 | 0 | Columbia UniversityOTHER | 0 | Mar 26, 2019 | clinicaltrials |
| NCT02317341 | Effect of Ketamine on Fatigue Following Cancer Therapy | terminated | Early Phase 1 | 2 | National Institute of Nursing Research (NINR)NIH | 1 | Mar 20, 2019 | clinicaltrials |
| NCT02768389 | Feasibility Trial of the Modified Atkins Diet and Bevacizumab for Recurrent Glioblastoma | completed | Early Phase 1 | 18 | Case Comprehensive Cancer CenterOTHER | 1 | Mar 15, 2019 | clinicaltrials |
| NCT01445054 | 111 Indium CHX-A DTPA Trastuzumab (Indium-Herceptin) for Imaging Breast Cancer | terminated | Early Phase 1 | 13 | National Cancer Institute (NCI)NIH | 1 | Mar 11, 2019 | clinicaltrials |
| NCT01286675 | Effect of Eltrombopag Plus G-CSF on Human CD34+ Cell Mobilization in Multiple Myeloma Patients Undergoing ASCT | completed | Early Phase 1 | 19 | Dana-Farber Cancer InstituteOTHER | 1 | Mar 1, 2019 | clinicaltrials |
| NCT03179956 | Impact of Ribociclib on Head and Neck Squamous Cell Cancer | terminated | Early Phase 1 | 1 | Fox Chase Cancer CenterOTHER | 1 | Feb 25, 2019 | clinicaltrials |
| NCT03822130 | Intra-arterial Infusion Chemotherapy Combined With Sodium Bicarbonate for Unresectable Gastric Cancer | unknown | Early Phase 1 | 150 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Feb 20, 2019 | clinicaltrials |
| NCT01666353 | PET Quantitative Assessments of Solid Tumor Response to Immune Checkpoint Blockade Therapy | completed | Early Phase 1 | 20 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Feb 8, 2019 | clinicaltrials |
| NCT02463994 | A Pilot Study of MPDL3280A and HIGRT in Metastatic NSCLC | completed | Early Phase 1 | 12 | University of Michigan Rogel Cancer CenterOTHER | 1 | Feb 8, 2019 | clinicaltrials |
| NCT03690310 | Study of Anti-CD19 CAR NK Cells in Relapsed and Refractory B Cell Lymphoma | unknown | Early Phase 1 | 9 | Allife Medical Science and Technology Co., Ltd.INDUSTRY | 0 | Jan 31, 2019 | clinicaltrials |
| NCT03692637 | Study of Anti-Mesothelin Car NK Cells in Epithelial Ovarian Cancer | unknown | Early Phase 1 | 30 | Allife Medical Science and Technology Co., Ltd.INDUSTRY | 0 | Jan 31, 2019 | clinicaltrials |
| NCT03824951 | Study of Anti-CD19 iCAR NK Cells in Relapsed and Refractory B Cell Lymphoma | unknown | Early Phase 1 | 10 | Allife Medical Science and Technology Co., Ltd.INDUSTRY | 0 | Jan 31, 2019 | clinicaltrials |
| NCT03824964 | Study of Anti-CD19/CD22 CAR NK Cells in Relapsed and Refractory B Cell Lymphoma | unknown | Early Phase 1 | 10 | Allife Medical Science and Technology Co., Ltd.INDUSTRY | 0 | Jan 31, 2019 | clinicaltrials |
| NCT03825731 | A Study of GC022 CAR-T Cell Immunotherapy for Relapsed or Refractory B- ALL | unknown | Early Phase 1 | 20 | Hebei Yanda Ludaopei HospitalOTHER | 1 | Jan 31, 2019 | clinicaltrials |
| NCT03692767 | Study of Anti-CD22 CAR NK Cells in Relapsed and Refractory B Cell Lymphoma | unknown | Early Phase 1 | 9 | Allife Medical Science and Technology Co., Ltd.INDUSTRY | 0 | Jan 30, 2019 | clinicaltrials |
| NCT02411565 | Fermented Wheat Germ Extract in Women With Ovarian Cancer | terminated | Early Phase 1 | 3 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Jan 23, 2019 | clinicaltrials |
| NCT00364364 | Safety Study to Determine the Appropriate Dose of Antibody Against Tumor Cells to Best Target Patients With Pancreatic Cancer. | terminated | Early Phase 1 | 2 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Jan 18, 2019 | clinicaltrials |
| NCT00499733 | Cyclophosphamide and Cryoablation in Treating Patients With Advanced or Metastatic Epithelial Cancer | terminated | Early Phase 1 | 19 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Jan 18, 2019 | clinicaltrials |
| NCT02847000 | p53/p16-Independent Epigenetic Therapy With Oral Decitabine/Tetrahydrouridine for Pancreatic Cancer | completed | Early Phase 1 | 13 | Yogen SaunthararajahOTHER | 1 | Jan 9, 2019 | clinicaltrials |
| NCT02846935 | p53/p16-Independent Epigenetic Therapy With Oral Decitabine/Tetrahydrouridine for Refractory/Relapsed Lymphoid Malignancies | completed | Early Phase 1 | 7 | Yogen SaunthararajahOTHER | 1 | Jan 7, 2019 | clinicaltrials |
| NCT03388814 | Speeding Recovery From Pain and Opioid Use | withdrawn | Early Phase 1 | 0 | Wake Forest University Health SciencesOTHER | 0 | Nov 30, 2018 | clinicaltrials |
| NCT00867126 | Pioglitazone as Second-Line in Patients With Metastatic Pancreatic Cancer After Treatment With Gemcitabine | terminated | Early Phase 1 | 6 | University of Texas Southwestern Medical CenterOTHER | 1 | Nov 26, 2018 | clinicaltrials |
| NCT02442739 | Ketamine for Preventing Depression in Patients Undergoing Treatment for Pancreatic or Head and Neck Cancers | withdrawn | Early Phase 1 | 0 | Cedars-Sinai Medical CenterOTHER | 1 | Nov 6, 2018 | clinicaltrials |
| NCT02836288 | Study of Oral Ketamine Versus Placebo for Treating Depression in Patients Undergoing Treatment for Cancer | completed | Early Phase 1 | 4 | Scott A. Irwin, MD, PhDOTHER | 1 | Nov 6, 2018 | clinicaltrials |
| NCT00212407 | New York Blood Center National Cord Blood Program | terminated | Early Phase 1 | 4,476 | New York Blood CenterOTHER | 1 | Nov 2, 2018 | clinicaltrials |
| NCT00640861 | Vaccine Therapy in Treating Patients With Previously Treated Stage II or Stage III Breast Cancer | completed | Early Phase 1 | 45 | Mayo ClinicOTHER | 1 | Oct 31, 2018 | clinicaltrials |
| NCT03208712 | Radium-223 and Atezolizumab in Patients With Urothelial Carcinoma With Bone Metastases Who Have Had Disease Progression After Platinum-Based Chemotherapy | terminated | Early Phase 1 | 1 | University of Michigan Rogel Cancer CenterOTHER | 1 | Oct 24, 2018 | clinicaltrials |
| NCT02450201 | MRI With C13 Pilot Study Prostate Cancer | terminated | Early Phase 1 | 5 | University of California, San FranciscoOTHER | 1 | Oct 23, 2018 | clinicaltrials |
| NCT00651976 | Letrozole in Treating Postmenopausal Women With Stage I, II or III Breast Cancer That Can Be Removed by Surgery | terminated | Early Phase 1 | 213 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | Oct 15, 2018 | clinicaltrials |
| NCT00662233 | Combination Chemotherapy in Treating Patients With Sarcoma | completed | Early Phase 1 | 28 | Mayo ClinicOTHER | 1 | Oct 9, 2018 | clinicaltrials |
| NCT01719250 | Buparlisib in Treating Patients With Relapsed or Refractory Non-Hodgkin Lymphoma | completed | Early Phase 1 | 7 | Mayo ClinicOTHER | 1 | Oct 9, 2018 | clinicaltrials |
| NCT01748747 | Vaccine Therapy and Resiquimod in Treating Patients With Stage II-IV Melanoma That Has Been Removed By Surgery | completed | Early Phase 1 | 30 | Mayo ClinicOTHER | 1 | Oct 9, 2018 | clinicaltrials |
| NCT02802748 | Phase 0 Study of Metronomic Oral Vinorelbine and Letrozole in HR+/HER2-negative Early Breast Cancer Patients (VENTANA) | completed | Early Phase 1 | 60 | SOLTI Breast Cancer Research GroupOTHER | 1 | Sep 20, 2018 | clinicaltrials |
| NCT03672305 | Clinical Study on the Efficacy and Safety of c-Met/PD-L1 CAR-T Cell Injection in the Treatment of HCC | unknown | Early Phase 1 | 50 | The Second Hospital of Nanjing Medical UniversityOTHER | 0 | Sep 18, 2018 | clinicaltrials |
| NCT01861340 | Lenalidomide, Dexamethasone and MEDI-551 in Untreated Multiple Myeloma | completed | Early Phase 1 | 20 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Sep 10, 2018 | clinicaltrials |
| NCT03661554 | BCMA Nano Antibody CAR-T Cells for Patients With Refractory and Relapsed Multiple Myeloma(BCMA CAR-T) | unknown | Early Phase 1 | 15 | The Pregene (ShenZhen) Biotechnology Company, Ltd.INDUSTRY | 1 | Sep 10, 2018 | clinicaltrials |
| NCT00986609 | MUC1 Vaccine for Triple-negative Breast Cancer | completed | Early Phase 1 | 29 | Joseph Baar, MD, PhDOTHER | 1 | Jul 23, 2018 | clinicaltrials |
| NCT01907165 | Disulfiram in Treating Patients With Glioblastoma Multiforme After Radiation Therapy With Temozolomide | completed | Early Phase 1 | 21 | Washington University School of MedicineOTHER | 1 | Jul 20, 2018 | clinicaltrials |
| NCT02115828 | A Study of Vismodegib in Men With Metastatic CRPC With Accessible Metastatic Lesions for Tumor Biopsy | completed | Early Phase 1 | 9 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Jul 20, 2018 | clinicaltrials |
| NCT02069080 | Imaging CXCR4 Expression in Subjects With Cancer Using 64 Cu-Plerixafor | terminated | Early Phase 1 | 2 | National Institute of Allergy and Infectious Diseases (NIAID)NIH | 1 | Jul 12, 2018 | clinicaltrials |
| NCT00601913 | Erlotinib and Surgery in Treating Patients With Head and Neck Cancer That Can Be Removed by Surgery | completed | Early Phase 1 | 24 | Wake Forest University Health SciencesOTHER | 1 | Jul 5, 2018 | clinicaltrials |
Data updated 24 days agoSource updated Apr 23, 2019source: clinicaltrials